Supreme Court of the United States
Skip Navigation LinksHome > Search Results



Docket for 21-1458
Print  Notify Me  
Search documents in this case:
No. 21-1458
 
Title: EPA Drug Initiative II, Petitioner
v.
Hikma Pharmaceuticals USA Inc., et al.
Docketed: May 18, 2022
Lower Ct: United States Court of Appeals for the Federal Circuit
   Case Numbers: (2021-2024)
   Decision Date: February 15, 2022
 
Proceedings and Orders
May 16 2022 Petition for a writ of certiorari filed. (Response due June 17, 2022)
Petition Certificate of Word Count Proof of Service
May 20 2022 Waiver of right of respondents Hikma Pharmaceuticals USA Inc.; Hikma Pharmaceuticals International Limited; West-Ward Pharmaceuticals International Limited (n/k/a Hikma Pharmaceuticals International Limited) to respond filed.
Main Document
May 23 2022 Waiver of right of respondent Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. to respond filed.
Main Document
Jun 07 2022 DISTRIBUTED for Conference of 6/23/2022.
Jun 27 2022 Petition DENIED.
Attorneys
Attorneys for Petitioners
Michael Scott Kasanoff
Counsel of Record
Michael S. Kasanoff, LLC
9 Stillwell Street
Matawan, NJ 07747

mkasanoff@att.net
Ph: 908-902-5900
Party name: EPA Drug Initiative II


Attorneys for Respondents
Charles Bennett Klein
Counsel of Record
Winston & Strawn LLP
1901 L Street NW
Washington, DC 20036

cklein@winston.com
Ph: 202-282-5977
Party name: Hikma Pharmaceuticals USA Inc.; Hikma Pharmaceuticals International Limited; West-Ward Pharmaceuticals International Limited (n/k/a Hikma Pharmaceuticals International Limited)


Constance S. Hunter
Windels Marx Lane & Mittendorf, LLP
One Giralda Farms
Madision, NJ 07006

chuttner@windelsmarx.com
Ph: 973-966-3206
Party name: Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.


 

SUPREME COURT OF THE UNITED STATES 1 First Street, NE Washington, DC 20543